Prof Jörn Schattenberg presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need

In this engaging discussion, Professor Jörn Schattenberg shares his groundbreaking research on the hepatic thyroid hormone pathway's impact on Nonalcoholic Steatohepatitis (NASH). He highlights the alarming increase in NASH cases and its significant mortality risks. The conversation delves into advancements in diagnosis and management strategies, including promising non-invasive testing methods. Schattenberg emphasizes the urgent need for innovative therapeutic solutions to address this growing health crisis and improve patient outcomes.